Effects of ceralasertib and durvalumab treatment on longitudinal blood-derived transcriptomes are depicted in the box plots showing differentially expressed interferon-α-associated signatures. P values are for comparisons with respective cycle 0, day (D) 1 time points. P values for visit dates represent linear mixed model effects, illustrating changes in on-treatment samples.
